The neuropathology and clinical phenotype of FTD with progranulin mutations
about
Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech.Mechanisms of granulin deficiency: lessons from cellular and animal modelsPotential mechanisms of progranulin-deficient FTLDHyperphosphorylation as a defense mechanism to reduce TDP-43 aggregationFrontotemporal dementia: a bridge between dementia and neuromuscular diseaseHippocampal sclerosis in Lewy body disease is a TDP-43 proteinopathy similar to FTLD-TDP Type AGranulin knock out zebrafish lack frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis pathologyFrontotemporal Dementia.Genetic and clinical features of progranulin-associated frontotemporal lobar degenerationOverexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion.Wild type human TDP-43 potentiates ALS-linked mutant TDP-43 driven progressive motor and cortical neuron degeneration with pathological features of ALS.Progranulin is expressed within motor neurons and promotes neuronal cell survivalThe unexpected co-occurrence of GRN and MAPT p.A152T in Basque families: Clinical and pathological characteristicsFrequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degenerationThe role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia.Biomarkers in frontotemporal lobar degenerations--progress and challenges.Accelerated lipofuscinosis and ubiquitination in granulin knockout mice suggest a role for progranulin in successful aging.Variations in the progranulin gene affect global gene expression in frontotemporal lobar degenerationFrontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management.Altered microRNA expression in frontotemporal lobar degeneration with TDP-43 pathology caused by progranulin mutations.Evaluation of subcortical pathology and clinical correlations in FTLD-U subtypes.Brain progranulin expression in GRN-associated frontotemporal lobar degenerationHippocampal sclerosis in the elderly: genetic and pathologic findings, some mimicking Alzheimer disease clinicallyClinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72TDP-43 pathology in a case of hereditary spastic paraplegia with a NIPA1/SPG6 mutationEntorhinal cortical neurons are the primary targets of FUS mislocalization and ubiquitin aggregation in FUS transgenic rats.Progranulin regulates neuronal outgrowth independent of sortilinProgranulin: an emerging target for FTLD therapies.Dissociation of frontotemporal dementia-related deficits and neuroinflammation in progranulin haploinsufficient mice.Molecular neuropathology of TDP-43 proteinopathies.Update on recent molecular and genetic advances in frontotemporal lobar degeneration.Pallidonigral TDP-43 pathology in Perry syndrome.Anterior brain glucose hypometabolism predates dementia in progranulin mutation carriersThe syndromes of frontotemporal dysfunction in amyotrophic lateral sclerosis.The molecular basis of frontotemporal dementia.Biomarkers in frontotemporal lobar degeneration.Biomarkers to identify the pathological basis for frontotemporal lobar degeneration.Clinical Subtypes of Frontotemporal Dementia.Biomarkers in the primary progressive aphasiasManagement of frontotemporal dementia: targeting symptom management in such a heterogeneous disease requires a wide range of therapeutic options.
P2860
Q24632112-877D8F0E-E2F6-4C19-AEBF-03D8733CD7A1Q26824221-7C7E10A2-45DC-4A6A-93CA-E0EB0A583903Q26863702-124498F5-879F-4BB9-BBE8-A50EFAA2DF24Q27325625-36A7C643-341D-400A-BF74-27FB8EC89518Q28081198-33FE31C1-C2EA-4FB3-A53D-7E7363F3FA65Q28250864-04F165C2-E77A-4C22-8C04-7B5E655C6323Q28544656-888F592F-C407-413F-B1F0-B462FE98F743Q30234793-584B0583-3CF1-48C7-A775-A7FA011FFBE7Q30503638-7AB5AC01-CC65-4522-9F02-4CFF21650A74Q30532680-06A262EA-98EA-48DB-9A8C-2663D4867906Q30655551-328C0F30-0259-4C95-B67F-FDE29247E9B0Q33513028-C262FFB8-46BA-4E5A-B5EC-7533A3BEDD58Q33778423-BE693206-FC08-433D-B9E3-94DE46C9D03CQ33830991-6FEFD67E-5406-4BEA-9434-C39EE1D80579Q33847532-5C998398-C7EA-415C-B45F-CDF38D503F48Q33893515-3A816312-D529-4F02-9C54-A83FF98C7DEDQ33947272-190027AD-3424-4084-BC13-8E9DC81AA4BDQ33978879-73BE9245-9E86-4982-B1DB-EFEA6641DF16Q34046590-434B82B5-9CF6-40C8-8857-55CBA0197764Q34059809-6FD4891A-2A70-4231-BB48-4D9ED241F64BQ34604146-D2236061-92FF-474E-820C-7C1FA34AF3FAQ35014879-B08B0474-1EA2-4DEA-8488-D96A4C8CC495Q35022179-11D1E7C2-0C5E-4797-ADE7-B596AE83D65DQ35752001-32D52F95-CE77-406E-ACF7-A48182E53614Q35992033-A66EA5FA-4E2B-4E23-93C4-CA067BE4FC58Q36317708-DDC0080B-CFAB-43F7-8D6A-8557BD0B5B28Q36430434-C73F09AB-D447-4E1F-9589-2368DBEFF562Q36826623-B7C2BC45-890B-462E-B9DB-7BA0DC3BBB2FQ37087755-63ABB07F-FC14-4504-9758-AC2CD4265620Q37143159-2C6966DA-99B7-41B6-A7CA-7022C46C303EQ37205729-9804E50D-B01B-4D06-AE8E-F828D1462F91Q37221392-0358728E-72D2-43B9-8511-89320078DFC1Q37251668-C47CC5C1-9A98-49C0-9373-36125A15B9C5Q37254394-AFFF7CC4-D9D6-4668-99F5-5E809D3EC25BQ37564674-E15CA779-4A87-4DCC-A3EB-17DA57F318B3Q37794615-559917E4-DC6E-4B35-89F0-C83DA02371F0Q37915345-C32953D2-A3BC-4154-B00F-A09035C49DA7Q38118236-18B37F56-C187-467F-9F0D-294695BD3803Q38314824-460BD660-17FE-4CEF-B9AE-627A3793FC50Q38391397-004F551A-0744-41B1-B777-5766C35F645A
P2860
The neuropathology and clinical phenotype of FTD with progranulin mutations
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The neuropathology and clinical phenotype of FTD with progranulin mutations
@ast
The neuropathology and clinical phenotype of FTD with progranulin mutations
@en
The neuropathology and clinical phenotype of FTD with progranulin mutations
@nl
type
label
The neuropathology and clinical phenotype of FTD with progranulin mutations
@ast
The neuropathology and clinical phenotype of FTD with progranulin mutations
@en
The neuropathology and clinical phenotype of FTD with progranulin mutations
@nl
prefLabel
The neuropathology and clinical phenotype of FTD with progranulin mutations
@ast
The neuropathology and clinical phenotype of FTD with progranulin mutations
@en
The neuropathology and clinical phenotype of FTD with progranulin mutations
@nl
P2860
P1476
The neuropathology and clinical phenotype of FTD with progranulin mutations
@en
P2093
Ian R A Mackenzie
P2860
P2888
P356
10.1007/S00401-007-0223-8
P407
P577
2007-07-01T00:00:00Z
P6179
1045146902